Mortality in Parenchymal and Subarachnoid Neurocysticercosis
- PMID: 34232912
- PMCID: PMC8274779
- DOI: 10.4269/ajtmh.20-1330
Mortality in Parenchymal and Subarachnoid Neurocysticercosis
Abstract
Neurocysticercosis (NCC) is endemic in many parts of the world, carrying significant neurological morbidity that varies according to whether lesions are located inside the cerebral parenchyma or in extraparenchymal spaces. The latter, in particular subarachnoid NCC, is assumed to be more severe, but no controlled studies comparing mortality between types of NCC exist. The aim of this study was to compare all-cause mortality between patients with intraparenchymal NCC and those with subarachnoid NCC. Vital status and sociodemographic characteristics were evaluated in patients with intraparenchymal viable, intraparenchymal calcified, and subarachnoid NCC attending a neurological referral hospital in Lima, Perú. Survival analyses using Kaplan-Meier curves and Cox proportional regression models were carried out to compare mortality rates between groups. From 840 NCC patients followed by a median time of 82.3 months, 42 (5.0%) died, six (1.8%) in the intraparenchymal viable group, four (1.3%) in the calcified group, and 32 (16.6%) in the subarachnoid group (P < 0.001). Older age and lower education were significantly associated with mortality. The age-adjusted hazard ratio for death in the subarachnoid group was 13.6 (95% CI: 5.6-33.0, P < 0.001) compared with the intraparenchymal viable group and 10.7 (95% CI: 3.7-30.8, P < 0.001) when compared with the calcified group. We concluded that subarachnoid disease is associated with a much higher mortality in NCC.
Figures
Similar articles
-
A Comparative Study of Peripheral Immune Responses to Taenia solium in Individuals with Parenchymal and Subarachnoid Neurocysticercosis.PLoS Negl Trop Dis. 2015 Oct 27;9(10):e0004143. doi: 10.1371/journal.pntd.0004143. eCollection 2015 Oct. PLoS Negl Trop Dis. 2015. PMID: 26506532 Free PMC article.
-
High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis.Neurology. 2012 May 1;78(18):1394-400. doi: 10.1212/WNL.0b013e318253d641. Epub 2012 Apr 18. Neurology. 2012. PMID: 22517102 Free PMC article.
-
Antibody Banding Patterns of the Enzyme-Linked Immunoelectrotransfer Blot and Brain Imaging Findings in Patients With Neurocysticercosis.Clin Infect Dis. 2018 Jan 6;66(2):282-288. doi: 10.1093/cid/cix774. Clin Infect Dis. 2018. PMID: 29020381 Free PMC article.
-
Reprint of "Neurocysticercosis-related mortality in Brazil, 2000-2011: Epidemiology of a neglected neurologic cause of death".Acta Trop. 2017 Jan;165:170-178. doi: 10.1016/j.actatropica.2016.11.009. Epub 2016 Nov 23. Acta Trop. 2017. PMID: 27887696 Review.
-
[Diagnostic and therapeutic difficulties in neurocysticercosis: presentation of 6 cases and review of the literature].Neurocirugia (Astur). 2007 Apr;18(2):101-10. Neurocirugia (Astur). 2007. PMID: 17497055 Review. Spanish.
Cited by
-
A Rapid Point-of-Care Assay for Cysticercosis Antigen Detection in Urine Samples.Am J Trop Med Hyg. 2023 Feb 6;108(3):578-580. doi: 10.4269/ajtmh.22-0598. Print 2023 Mar 1. Am J Trop Med Hyg. 2023. PMID: 36746658 Free PMC article.
-
Seroprevalence and Risk Factors for Cysticercosis in Mexican Americans in Starr County, Texas.Pathogens. 2024 Nov 12;13(11):988. doi: 10.3390/pathogens13110988. Pathogens. 2024. PMID: 39599541 Free PMC article.
-
Immunologic Profiling of CSF in Subarachnoid Neurocysticercosis Reveals Specific Interleukin-10-Producing Cell Populations During Treatment.Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200320. doi: 10.1212/NXI.0000000000200320. Epub 2024 Oct 30. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39475624 Free PMC article.
-
Oxidative Stress in the Murine Model of Extraparenchymal Neurocysticercosis.Microorganisms. 2024 Sep 8;12(9):1860. doi: 10.3390/microorganisms12091860. Microorganisms. 2024. PMID: 39338534 Free PMC article.
-
A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis.PLoS Negl Trop Dis. 2022 May 26;16(5):e0010442. doi: 10.1371/journal.pntd.0010442. eCollection 2022 May. PLoS Negl Trop Dis. 2022. PMID: 35617367 Free PMC article.
References
-
- Fabiani S, Bruschi F, 2013. Neurocysticercosis in Europe: still a public health concern not only for imported cases. Acta Trop 128: 18–26. - PubMed
-
- Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T, 2011. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 9: 123–133. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources